|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical Relevance of urokinase-type plasminogen activator,its receptor, and its inhibitor type 1 in endometrial cancer显示文摘 | TECIMER C DOERING D L GOLDSMITH L J | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 2 | Clinical relevance of urokinase-type plasminogen activator,its receptor and inhibitor type 1 in ovarian cancer显示文摘 | Tecimer C Doering D L Goldsmith L J | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 3 | Clinical relevance of urokinase- type plasminogen activator,its receptor, and its inhibitor type 1 in endometrial cancer显示文摘 | Tecimer C Doefing DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 4 | Clinical relevance of urokinase-type plasminogen activator,its receptor,and its inhibitor type I in endometrial cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 5 | Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment显示文摘 | La Heij EC Tecim S Kessels AG Liem AT Japing WJ Hendrikse F | 2004 | Graefes Arch Clin Exp Ophthalmol2004，242，3： | 1 |
| 6 | Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endome-trial cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 7 | Clinical relevance of urokinase-type plasminogen activator,its receptor and inhibitor type 1 in ovarian cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 8 | Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment显示文摘 | Ellen C. Heij Sadettin Tecim Alfons G. H. Kessels Albert T. A. Liem Wouter J. Japing Fred Hendrikse | 2004 | Graefe’s Archive for Clinical and Experimental Ophthalmology2004，，3： | 1 |
| 9 | Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer 显示文摘 | Tecimer C Doering DL Goldsmith LJ Meyer JS Abdulhay G Wittliff JL | 2000 | Int J Gynccol Cancer2000，10，5： | 1 |
| 10 | Dynamically tunable mirrors for THz free electron laserapplications显示文摘 | Tecimer M Holldack K Elias L R | | 0，，： | 1 |
| 11 | Clinical relevance of urokinase - type plasminogen activator,its receptor and inhibitor type 1 in ovarian cancer 显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 12 | Clinical relevance of urokinase-type plasminegen activator,its receptor,and its in-hibitor type 1 in endometrial cancer显示文摘 | Doerieg DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 13 | Dynamically tunable mirrors for THz free electron laser applications显示文摘 | TECIMER M HOLLDACK K ELIAS L R | 2010 | Phys Rev ST Accel Beams2010，13，03： | 1 |
| 14 | Effects of gibberellic acid and benzophenone on mice 显示文摘 | Ustun H Tecimer T Ozmen M | 1992 | Histopatalogic Review : Ank Patol Bait1992，9，： | 1 |
| 15 | Photovoltaic characteristics of AulPVA (Bi-dopedj/n-Si Schottky barrier diodes (SBDs) at various temperatures显示文摘 | < ::ETINKAYA H G TECIMER H USLU H | 2013 | Current Applied Physics2013，13，6： | 1 |
| 16 | Dynamically tunable mirrors for THz free electron laser applicatiun显示文摘 | Tecimer M Holldack K Elias L R | 2010 | Phys Rev ST Accel Beams2010，13，3： | 1 |
| 17 | Clinical revelence of urokinase-type plasminogen activator,its receptor and inhibitor type-1 in ovarion cancer显示文摘 | TECIMER C DOERING D L GOLDSMITH L J | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 18 | Chnical relevance of urokinase-type plasminogen activator, its receptor and inhibitor typel in ovarianc ancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 19 | Clinical relevance of urokinase - type plasminogan activator, its receptor, and its inhibitor type 1 in endometrial cancer 显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecal Oncol2001，80，1： | 1 |
| 20 | Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells显示文摘 | Tecimer T Dlott J Chuntharapai A | 2000 | Arch Pathol Lab Med2000，124，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员